Larson, Nate <br/><br/>
Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.  [electronic resource] 

 -  International journal of pharmaceutics  Sep 2013 
 - 435-43 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2013.06.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cathepsin B--chemistry<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Chemistry, Pharmaceutical<br/>Deoxycytidine--administration & dosage<br/>Drug Carriers<br/>Drug Stability<br/>Drug Synergism<br/>Female<br/>Humans<br/>Hydrogen-Ion Concentration<br/>Hydrolysis<br/>Kinetics<br/>Male<br/>Molecular Weight<br/>Ovarian Neoplasms--pathology<br/>Paclitaxel--administration & dosage<br/>Polymerization<br/>Polymethacrylic Acids--chemistry<br/>Solubility<br/>Technology, Pharmaceutical--methods<br/>Gemcitabine